Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 1
1963 1
1965 1
1969 1
1970 1
1973 1
1975 3
1976 4
1977 3
1978 3
1979 8
1980 11
1981 13
1982 5
1983 11
1984 8
1985 11
1986 17
1987 10
1988 19
1989 12
1990 15
1991 26
1992 26
1993 22
1994 19
1995 17
1996 23
1997 23
1998 17
1999 20
2000 29
2001 27
2002 25
2003 29
2004 24
2005 24
2006 15
2007 27
2008 29
2009 26
2010 34
2011 34
2012 37
2013 50
2014 49
2015 60
2016 72
2017 83
2018 92
2019 81
2020 119
2021 126
2022 49
Text availability
Article attribute
Article type
Publication date

Search Results

1,374 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Familial Hypercholesterolemia: A Reportable Disorder.
Kullo IJ. Kullo IJ. Circulation. 2020 Nov 24;142(21):1999-2001. doi: 10.1161/CIRCULATIONAHA.120.050548. Epub 2020 Nov 23. Circulation. 2020. PMID: 33226870 Free PMC article. Review. No abstract available.
Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action.
Representatives of the Global Familial Hypercholesterolemia Community, Wilemon KA, Patel J, Aguilar-Salinas C, Ahmed CD, Alkhnifsawi M, Almahmeed W, Alonso R, Al-Rasadi K, Badimon L, Bernal LM, Bogsrud MP, Braun LT, Brunham L, Catapano AL, Cillíková K, Corral P, Cuevas R, Defesche JC, Descamps OS, de Ferranti S, Eiselé JL, Elikir G, Folco E, Freiberger T, Fuggetta F, Gaspar IM, Gesztes ÁG, Grošelj U, Hamilton-Craig I, Hanauer-Mader G, Harada-Shiba M, Hastings G, Hovingh GK, Izar MC, Jamison A, Karlsson GN, Kayikçioglu M, Koob S, Koseki M, Lane S, Lima-Martinez MM, López G, Martinez TL, Marais D, Marion L, Mata P, Maurina I, Maxwell D, Mehta R, Mensah GA, Miserez AR, Neely D, Nicholls SJ, Nohara A, Nordestgaard BG, Ose L, Pallidis A, Pang J, Payne J, Peterson AL, Popescu MP, Puri R, Ray KK, Reda A, Sampietro T, Santos RD, Schalkers I, Schreier L, Shapiro MD, Sijbrands E, Soffer D, Stefanutti C, Stoll M, Sy RG, Tamayo ML, Tilney MK, Tokgözoglu L, Tomlinson B, Vallejo-Vaz AJ, Vazquez-Cárdenas A, de Luca PV, Wald DS, Watts GF, Wenger NK, Wolf M, Wood D, Zegerius A, Gaziano TA, Gidding SS. Representatives of the Global Familial Hypercholesterolemia Community, et al. JAMA Cardiol. 2020 Feb 1;5(2):217-229. doi: 10.1001/jamacardio.2019.5173. JAMA Cardiol. 2020. PMID: 31895433
IMPORTANCE: Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to premature morbidity and mortality due to atherosclerotic cardiovascular disease. Familial hypercholesterolemia affects 1 i …
IMPORTANCE: Familial hypercholesterolemia (FH) is an underdiagnosed and undertreated genetic disorder that leads to pre …
Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-Analysis.
Hu P, Dharmayat KI, Stevens CAT, Sharabiani MTA, Jones RS, Watts GF, Genest J, Ray KK, Vallejo-Vaz AJ. Hu P, et al. Circulation. 2020 Jun 2;141(22):1742-1759. doi: 10.1161/CIRCULATIONAHA.119.044795. Epub 2020 May 29. Circulation. 2020. PMID: 32468833
BACKGROUND: Contemporary studies suggest that familial hypercholesterolemia (FH) is more frequent than previously reported and increasingly recognized as affecting individuals of all ethnicities and across many regions of the world. ...Studies reporting
BACKGROUND: Contemporary studies suggest that familial hypercholesterolemia (FH) is more frequent than previously reported
PCSK9 inhibition in the management of familial hypercholesterolemia.
Ogura M. Ogura M. J Cardiol. 2018 Jan;71(1):1-7. doi: 10.1016/j.jjcc.2017.07.002. Epub 2017 Aug 5. J Cardiol. 2018. PMID: 28784313 Free article. Review.
Familial hypercholesterolemia (FH) is a frequent hereditary metabolic disease characterized by high serum low-density lipoprotein (LDL) cholesterol concentration and premature atherosclerotic cardiovascular disease (ASCVD). ...Further research r
Familial hypercholesterolemia (FH) is a frequent hereditary metabolic disease characterized by high serum low-density l
Statins for children with familial hypercholesterolemia.
Vuorio A, Kuoppala J, Kovanen PT, Humphries SE, Tonstad S, Wiegman A, Drogari E, Ramaswami U. Vuorio A, et al. Cochrane Database Syst Rev. 2019 Nov 7;2019(11):CD006401. doi: 10.1002/14651858.CD006401.pub5. Cochrane Database Syst Rev. 2019. PMID: 31696945 Free PMC article.
BACKGROUND: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant disorder meaning heterozygotes, or carriers, are affected. ...Coronary atherosclerosis has been detected in men with heterozygous …
BACKGROUND: Familial hypercholesterolemia is one of the most common inherited metabolic diseases and is an autosomal dominant …
[Familial hypercholesterolemia: A largely underestimated cardiovascular risk].
Ferrières J, Bruckert É, Béliard S, Rabès JP, Farnier M, Krempf M, Cariou B, Danchin N. Ferrières J, et al. Ann Cardiol Angeiol (Paris). 2018 Feb;67(1):1-8. doi: 10.1016/j.ancard.2017.04.015. Epub 2017 May 31. Ann Cardiol Angeiol (Paris). 2018. PMID: 28576280 French.
RESULTS: Thirty-two percent (95% CI [27.8; 36.2]) of physicians reported the difference between polygenic hypercholesterolemia and familial hypercholesterolemia. ...CONCLUSION: The lack of knowledge of heterozygous familial hypercholesterolem
RESULTS: Thirty-two percent (95% CI [27.8; 36.2]) of physicians reported the difference between polygenic hypercholesterolemia
20-Year Follow-up of Statins in Children with Familial Hypercholesterolemia.
Luirink IK, Wiegman A, Kusters DM, Hof MH, Groothoff JW, de Groot E, Kastelein JJP, Hutten BA. Luirink IK, et al. N Engl J Med. 2019 Oct 17;381(16):1547-1556. doi: 10.1056/NEJMoa1816454. N Engl J Med. 2019. PMID: 31618540
BACKGROUND: Familial hypercholesterolemia is characterized by severely elevated low-density lipoprotein (LDL) cholesterol levels and premature cardiovascular disease. ...CONCLUSIONS: In this study, initiation of statin therapy during childhood in patients wit …
BACKGROUND: Familial hypercholesterolemia is characterized by severely elevated low-density lipoprotein (LDL) cholesterol leve …
Worldwide Prevalence of Familial Hypercholesterolemia: Meta-Analyses of 11 Million Subjects.
Beheshti SO, Madsen CM, Varbo A, Nordestgaard BG. Beheshti SO, et al. J Am Coll Cardiol. 2020 May 26;75(20):2553-2566. doi: 10.1016/j.jacc.2020.03.057. J Am Coll Cardiol. 2020. PMID: 32439005 Free article.
BACKGROUND: Despite the greater prevalence of familial hypercholesterolemia (FH) in subjects with ischemic heart disease (IHD), premature IHD, and severe hypercholesterolemia (low-density lipoprotein 190 mg/dl), overall prevalence estimates are not ava …
BACKGROUND: Despite the greater prevalence of familial hypercholesterolemia (FH) in subjects with ischemic heart disease
Half a Century Tales of Familial Hypercholesterolemia (FH) in Japan.
Mabuchi H. Mabuchi H. J Atheroscler Thromb. 2017 Mar 1;24(3):189-207. doi: 10.5551/jat.RV16008. Epub 2017 Feb 8. J Atheroscler Thromb. 2017. PMID: 28179607 Free PMC article. Review.
Familial hypercholesterolemia (FH) is a disease characterized by a triad: elevated low-density lipoprotein (LDL) cholesterol, tendon xanthomas, and premature coronary heart disease. Thus, it can be considered as a model disease for hyperchole
Familial hypercholesterolemia (FH) is a disease characterized by a triad: elevated low-density lipoprotein (LDL) choles
The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia.
Hu H, Chen R, Hu Y, Wang J, Lin S, Chen X. Hu H, et al. Lipids Health Dis. 2021 Sep 12;20(1):101. doi: 10.1186/s12944-021-01536-3. Lipids Health Dis. 2021. PMID: 34511120 Free PMC article.
BACKGROUND: As an autosomal dominant disorder, familial hypercholesterolemia (FH) is mainly attributed to disease-causing variants in the low-density lipoprotein receptor (LDLR) gene. The aim of this study was to explore the molecular mechanism of LDLR …
BACKGROUND: As an autosomal dominant disorder, familial hypercholesterolemia (FH) is mainly attributed to disease
1,374 results